LEVODOPA PHARMACODYNAMICS

被引：0
|
作者：
CONTIN, M
RIVA, R
MARTINELLI, P
CORTELLI, P
ALBANI, F
BARUZZI, A
机构：
来源：
NEUROLOGY | 1994年 / 44卷 / 02期
关键词：
D O I：
10.1212/WNL.44.2.366
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：366 / 366
页数：1
相关论文
共 50 条
  • [21] Nonlinear pharmacodynamics of levodopa through Parkinson's disease progression
    Veronneau-Veilleux, Florence
    Ursino, Mauro
    Robaey, Philippe
    Levesque, Daniel
    Nekka, Fahima
    CHAOS, 2020, 30 (09)
  • [22] ACUTE EFFECTS OF PULSATILE LEVODOPA ADMINISTRATION ON CENTRAL DOPAMINE PHARMACODYNAMICS
    DAVIS, TL
    BRUGHITTA, G
    BARONTI, F
    MOURADIAN, MM
    NEUROLOGY, 1991, 41 (05) : 630 - 633
  • [23] The mpact of Manually Controlled Portable Duodopa Pump on Levodopa Pharmacokinetics and Pharmacodynamics
    Pravika, M.
    Jacob, Jeevamma
    Joseph, Paul K.
    PROCEEDINGS OF THE 2019 IEEE REGION 10 CONFERENCE (TENCON 2019): TECHNOLOGY, KNOWLEDGE, AND SOCIETY, 2019, : 696 - 701
  • [24] Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis
    Marsot, Amelie
    Guilhaumou, Romain
    Azulay, Jean-Philippe
    Blin, Olivier
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 : 226 - 238
  • [25] Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics
    Dingemanse, J
    Kleinbloesem, CH
    Zurcher, G
    Wood, ND
    Crevoisier, C
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) : 41 - 48
  • [26] Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease
    Chen, Cuiping
    Cowles, Verne E.
    Sweeney, Michael
    Stolyarov, Igor D.
    Illarioshkin, Sergey N.
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (02) : 67 - 72
  • [27] DEPRENYL EFFECTS ON LEVODOPA PHARMACODYNAMICS, MOOD, AND FREE-RADICAL SCAVENGING
    BARONTI, F
    DAVIS, TL
    BOLDRY, RC
    MOURADIAN, MM
    CHASE, TN
    NEUROLOGY, 1992, 42 (03) : 541 - 544
  • [28] Pharmacodynamics of benserazide as assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.
    Crevoisier, C
    Dingemanse, J
    Zurcher, G
    McClelland, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII69 - PII69
  • [29] EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
    NUTT, JG
    WOODWARD, WR
    STONE, CK
    BECKNER, RM
    CARTER, JH
    GANCHER, ST
    HAMMERSTAD, JP
    GORDIN, A
    NEUROLOGY, 1993, 43 (04) : A332 - A332
  • [30] Disease progression and pharmacodynamics in Parkinson disease - Evidence for functional protection with levodopa and other treatments
    Holford, Nicholas H. G.
    Chan, Phylinda L. S.
    Nutt, John G.
    Kieburtz, Karl
    Shoulson, Ira
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) : 281 - 311
12345